{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:54Z","timestamp":1790710974563,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12032-021-01533-7","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T10:02:51Z","timestamp":1625047371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can the host immune response against SARS-CoV2 also cause an anticancer effect?"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-6554","authenticated-orcid":false,"given":"Seda","family":"Kahraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Bulent","family":"Akinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali Nahit","family":"Sendur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"issue":"6","key":"1533_CR1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783\u201391.","journal-title":"Cancer Discov"},{"issue":"7","key":"1533_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","volume":"6","author":"J Yu","year":"2020","unstructured":"Yu J, et al. SARS-CoV-2 transmission in patients with cancer at a tertiary care Hospital in Wuhan China. JAMA Oncol. 2020;6(7):1108\u201310.","journal-title":"JAMA Oncol"},{"issue":"3","key":"1533_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"issue":"10241","key":"1533_CR4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","volume":"395","author":"LY Lee","year":"2020","unstructured":"Lee LY, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919\u201326.","journal-title":"Lancet"},{"issue":"4","key":"1533_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418\u201323.","journal-title":"J Med Virol"},{"issue":"2","key":"1533_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, et al. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102\u20138.","journal-title":"J Pharm Anal"},{"issue":"9","key":"1533_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/17476348.2020.1778470","volume":"14","author":"C Robba","year":"2020","unstructured":"Robba C, et al. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020;14(9):865\u20138.","journal-title":"Expert Rev Respir Med"},{"issue":"10229","key":"1533_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"12","key":"1533_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1055\/s-0040-1721319","volume":"120","author":"CJ Mycroft-West","year":"2020","unstructured":"Mycroft-West CJ, et al. Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin. Thromb Haemost. 2020;120(12):1700\u201315.","journal-title":"Thromb Haemost"},{"issue":"6024","key":"1533_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science. 2011;331(6024):1565\u201370.","journal-title":"Science"},{"issue":"3","key":"1533_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.17116","volume":"192","author":"S Challenor","year":"2021","unstructured":"Challenor S, Tucker D. SARS-CoV-2-induced remission of Hodgkin lymphoma. Br J Haematol. 2021;192(3):415.","journal-title":"Br J Haematol"},{"issue":"6","key":"1533_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.clml.2012.06.007","volume":"12","author":"TW Buckner","year":"2012","unstructured":"Buckner TW, et al. Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections. Clin Lymphoma Myeloma Leuk. 2012;12(6):455\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"1533_CR13","doi-asserted-by":"publisher","first-page":"1807836","DOI":"10.1080\/2162402X.2020.1807836","volume":"9","author":"C Melenotte","year":"2020","unstructured":"Melenotte C, et al. Immune responses during COVID-19 infection. Oncoimmunology. 2020;9(1):1807836.","journal-title":"Oncoimmunology"},{"issue":"1","key":"1533_CR14","doi-asserted-by":"publisher","first-page":"e000933","DOI":"10.1136\/jitc-2020-000933","volume":"8","author":"RJ Sullivan","year":"2020","unstructured":"Sullivan RJ, et al. COVID-19 and immune checkpoint inhibitors: initial considerations. J Immunother Cancer. 2020;8(1):e000933.","journal-title":"J Immunother Cancer"},{"issue":"3\u20134","key":"1533_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00508-017-1285-9","volume":"130","author":"C Thallinger","year":"2018","unstructured":"Thallinger C, et al. Review of cancer treatment with immune checkpoint inhibitors: current concepts, expectations, limitations and pitfalls. Wien Klin Wochenschr. 2018;130(3\u20134):85\u201391.","journal-title":"Wien Klin Wochenschr"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-021-01533-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T03:19:48Z","timestamp":1672629588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-021-01533-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1007\/s12032-021-01533-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"assertion":[{"value":"26 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors indicated no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"90"}}